Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
DPRX | hg38_v1_chr19_+_53632056_53632056 | -0.15 | 4.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_67196791 Show fit | 3.01 |
ENST00000256447.5
|
CD180 molecule |
|
chr16_+_83978545 Show fit | 2.82 |
ENST00000566836.1
|
N-terminal EF-hand calcium binding protein 2 |
|
chr18_-_66604076 Show fit | 2.30 |
ENST00000540086.5
ENST00000580157.2 ENST00000262150.7 |
cadherin 19 |
|
chr6_-_83709019 Show fit | 2.23 |
ENST00000519779.5
ENST00000369694.6 ENST00000195649.10 |
synaptosome associated protein 91 |
|
chr2_-_157327699 Show fit | 1.90 |
ENST00000397283.6
|
ermin |
|
chr20_+_10218808 Show fit | 1.86 |
ENST00000254976.7
ENST00000304886.6 |
synaptosome associated protein 25 |
|
chr6_-_83709141 Show fit | 1.76 |
ENST00000521743.5
|
synaptosome associated protein 91 |
|
chrX_+_101078861 Show fit | 1.76 |
ENST00000372930.5
|
transmembrane protein 35A |
|
chr16_+_81238682 Show fit | 1.76 |
ENST00000258168.7
ENST00000564552.1 |
beta-carotene oxygenase 1 |
|
chr12_-_6700788 Show fit | 1.64 |
ENST00000320591.9
ENST00000534837.6 |
PILR alpha associated neural protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.8 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 3.6 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.7 | 3.5 | GO:0002357 | defense response to tumor cell(GO:0002357) |
0.8 | 3.3 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.0 | 3.3 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.4 | 3.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.6 | 2.8 | GO:1904021 | negative regulation of G-protein coupled receptor internalization(GO:1904021) |
0.0 | 2.6 | GO:0045453 | bone resorption(GO:0045453) |
0.0 | 2.5 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 2.4 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 6.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 3.6 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 3.5 | GO:0044194 | cytolytic granule(GO:0044194) |
0.5 | 3.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 3.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 2.0 | GO:0031672 | A band(GO:0031672) |
0.2 | 1.9 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 1.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 1.7 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.3 | 1.6 | GO:0097179 | protease inhibitor complex(GO:0097179) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 4.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 3.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 3.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 3.3 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 3.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.7 | 2.8 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.0 | 2.4 | GO:1901476 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
0.0 | 1.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 1.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 3.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 2.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 1.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 1.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 1.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 1.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 1.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.4 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 3.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 2.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 2.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 1.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |